Neurolepsin (Lithium Carbonate)

Lithium carbonate modulates intracellular signaling pathways, most notably by inhibiting the enzyme inositol monophosphatase. This action reduces the recycling of inositol, dampening phosphoinositide signaling cascades that influence neuronal excitability. Lithium also affects glycogen synthase kinase‑3β and other second‑messenger systems, contributing to its overall mood‑stabilizing effect.

The appropriate dose of Neurolepsin is individualized and set by the prescribing clinician. Dosage decisions are based on factors such as the patient’s age, renal function, serum lithium levels, and clinical response. Regular monitoring of blood lithium concentrations guides dose adjustments to maintain therapeutic levels while minimizing toxicity.

The safety of lithium carbonate in pregnancy and lactation is not fully established. It is classified as having an unknown pregnancy category, and potential risks to the fetus or infant must be weighed against the benefits to the mother. Clinicians should discuss alternative options and closely monitor any pregnant or nursing patient who requires treatment.

To request Neurolepsin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets. After receiving the request, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details and any necessary import documentation.

Neurolepsin (lithium carbonate) is the prototypical mood stabilizer and has a long history of efficacy in bipolar disorder. Compared with anticonvulsant mood stabilizers such as valproate or carbamazepine, lithium offers robust protection against suicide risk but requires more intensive serum level monitoring. Its side‑effect profile differs, with a higher incidence of thyroid and renal considerations.

Neurolepsin should be stored at room temperature, below 25 °C. Keep the tablets in the original container, protect them from moisture and direct light, and ensure the packaging remains tightly closed to maintain product stability throughout its shelf life.

Neurolepsin is taken orally, usually in tablet form, as directed by the prescribing physician. The medication is swallowed with a full glass of water, and dosing times are often spaced evenly throughout the day to maintain stable serum levels. Patients should follow the clinician’s schedule and not alter the regimen without medical advice.

The most serious risks include lithium toxicity, which can present with neurological symptoms such as confusion, seizures, or coma, and may be precipitated by high serum levels. Long‑term use can also lead to renal impairment and thyroid dysfunction, requiring periodic monitoring of kidney and thyroid function tests to detect early changes.

Neurolepsin is contraindicated in patients with severe renal impairment, known hypersensitivity to lithium, or those taking medications that markedly increase lithium concentrations without appropriate monitoring. Caution is also advised for individuals with significant cardiovascular disease, uncontrolled thyroid disorders, or those who are unable to maintain adequate hydration.